|Thursday, June 26, 2014||Contact: Robin Mounsey, British Horseracing Authority |
|BHA announces zero-tolerance policy towards anabolic steroids|
BHA announces zero-tolerance policy towards anabolic steroids
The British Horseracing Authority (BHA) has today published details of British Racing’s enhanced, zero-tolerance policy towards the use of anabolic steroids.
The announcement of the policy marks the conclusion of a project initiated in 2013 to establish how British Racing would not only adhere to, but exceed where possible, the new international minimum standards on steroid use, as published by the International Federation of Horseracing Authorities (IFHA) in October 2013.
The project included extensive scientific research and consultation across the global Racing industry and externally, led by Sandy Love, Professor of Equine Clinical Studies at Glasgow University.
The headline elements of the policy are:
Paul Bittar, Chief Executive of BHA, said:
“The need for an international position that sets robust minimum standards on use of anabolic steroids in horseracing was one that was pushed by BHA and a number of other key racing jurisdictions last year and resulted in the IFHA adopted position.
“The enhanced, zero-tolerance policy announced today, which exceeds the international minimum standard, has the objective of ensuring that British Racing remains at the forefront of tackling an issue that ranks amongst the biggest threats faced by any world sport.
“After a challenging 16 months, as a result of the actions taken already by several nations, the sport globally is now in a much better place when it comes to the regulation of anabolic steroids.”
The intention is for the policy to be implemented by 1 January 2015, incorporated the 2015 foal crop, pending the implementation of the necessary Rule changes.
Jamie Stier, Director of Raceday Operations and Regulation for BHA, said:
“The development of this policy has been an extensive and exhaustive project which has taken place over a period of more than seven months.
“The initial research stage included a series of consultation meetings with a wide group of stakeholders including racing industry organisations, thoroughbred sales companies, veterinary organisations, scientific experts and animal welfare charities. This process was led by Sandy Love, Professor of Equine Clinical Studies at Glasgow University.
“Also included was a review of relevant scientific literature in relation to the therapeutic use of anabolic steroids, their possible performance enhancing effects and methods of detection.
Notes to Editors:
1. Full details of the policy are attached to this press release.
3. Details of BHA’s enhanced general Anti-Doping policy, published in December 2013 and effective from 1 January 2014, can be found here: http://www.britishhorseracing.presscentre.com/Press-Releases/BHA-enhances-anti-doping-Policy-467.aspx
6. Details of numbers of horses imported and foreign runners in 2013:
|For additional information, please visit www.britishhorseracing.presscentre.com/Press-Releases/BHA-announces-zero-tolerance-policy-towards-anabolic-steroids-4d5.aspx|
|E-Mail : firstname.lastname@example.org|